does retatrutide increase sex drive is a triple-agonist drug targeting GLP-1, GIP, and glucagon receptors to suppress appetite and boost thermogenesis. Phase 2 trials reported 24.2% average weight loss and over 80% liver fat reduction, reversing Triple hormone receptor agonist retatrutide
Description
Several mechanisms may contribute: Rapid dietary restriction : GLP1 medications significantly reduce appetite, which can lead to a sharp drop in caloric intake
Licensed healthcare providers may also prescribe Mounjaro off-label for weight loss when medically appropriate, based on individual clinical evaluation
A plausible strategy is a two-phase approach: - A state-perturbation (e.g., psychedelic-induced relaxation of rigid hierarchical priors) to loosen maladaptive attractors
Chelakkot et al., 2018
Together, we strive for healthier lives and stronger communities
